MCDM or multiple-criteria decision analysis (MCDA) comprises a set of methods, techniques or approaches that explicitly consider multiple criteria in decision-making environments and allows them to be combined in a single appraisal. The use of MCDA in health care is steadily increasing, in particular in health technology assessment and in formulary listing decisions. Structuring complex problems appropriately and considering multiple criteria explicitly is expected to lead to more informed, transparent and consistent decisions.

The ZRx MCDM tool has been developed as a highly flexible, user-friendly and powerful decision support tool. The tool has been designed to facilitate the application of local MCDM in health care and has been developed based on published and established MCDM methods.

The key information relevant to the decision problem, including the defined alternatives, criteria and weightings, needs to be manually added to the ZRx MCDM tool by the registered user. Once this has been done various analyses can be generated as outputs to support the defined decision. It is important to verify that the aggregate scores estimated reflect the expectations of stakeholders. Also, there may be substantial disagreement within a group of stakeholders around the details of a decision and so it may be necessary to analyze more than one formulation of a decision problem.

ZRx Outcomes Research Inc. aims to sell an annual subscription to the ZRx MCDM tool. The subscription entitles purchasers to updates of the tool, when further improvements or new functionalities have been added. Furthermore a subscription entitles purchasers to access to training and helpdesk facilities when needed. A single subscription allows for up to four individual users. Currently, access to the ZRx MCDM tool is online only.

For further information and to book a demonstration of the tool via WebEx you can contact our account managers:

Aleksandra Stojanović, MSc
+1 (647) 272-0170
Email: aleksandra@outcomesresearch.ca

Prof. Vladimir Zah, DPhil, ACIM, CPIAPD
+1 (416) 953-4427
Email: vzah@outcomesresearch.ca

Looking forward to hearing from you!

We have developed this tool with the top pricing strategists in the pharmaceutical industry in mind. With IRP expanding to cover more than 40 markets, the majority being in Europe, it has become a complex and cumbersome endeavour to estimate the global pricing impact of a product price change in a single market. Moreover, many countries are currently considering the introduction of IRP as a powerful cost-containment method that has already proved to be effective elsewhere.

We are confident that our IRP tool will meet your needs in establishing the impact of International Reference Pricing on your branded products because we developed Orange with the help and advice from experienced pricing strategists from the pharmaceutical industry. We made it easy to use in your own IT environment, for any branded product whose pricing is subject to IRP. Once you have added your product's pricing data for analysis you are only a few clicks away from the results. You can run as many analyses as you wish, and save or print the results. Your subscription entitles you to regular updates of the tool (for example new IRP rules, new IRP countries, further improvements and new functionalities), as well as access to training and helpdesk facilities.

We would be very happy to give you a demonstration of the Orange tool and the opportunity to play with it to appreciate fully its user-friendly design and value it can bring to your company.

For further information and to book a demonstration of the tool via WebEx you can contact our account managers:

Aleksandra Stojanović, MSc
+1 (647) 272-0170
Email: aleksandra@outcomesresearch.ca

Prof. Vladimir Zah, DPhil, ACIM, CPIAPD
+1 (416) 953-4427
Email: vzah@outcomesresearch.ca

Looking forward to hearing from you!